Kenta Nakamura

Interventional cards @UWMedHeart @VAPugetSound Translational scientist @UWMedicine @UWISCRM Associate Professor @UW

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”

[Kenta Nakamura @KentaMD]

First ever engraftment and maturation of autologous iPSC-cardios post-infarct without immunosuppression (out to 14 months). Incredible bicoastal collab with Cindy Dunbar & Manfred Boehm’s team @nih_nhlbi to pull this off—what a journey!
@UWISCRM @UWMedicine

[Cell Stem Cell @CellStemCell]

Online Now! Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques https://t.co/cZNCzp9gAO #stemcells

[Kenta Nakamura @KentaMD]

@DrEugeneYang @chrisryanburke @KateKearney4 @DrBillLombardi @PatrickGoleski @DrKelleyBranch @UWMedicine Thanks, Eugene! Will be asking for your help in the forthcoming pivotal trial.

[Kenta Nakamura @KentaMD]

Many thanks to @chrisryanburke, @KateKearney4, @DrBillLombardi, @PatrickGoleski and @DrKelleyBranch for making this important trial possible with @UWMedicine as the lead enrolling site!

[CircInterventions @CircIntv]

Epicardial Gene Therapy for Refractory Angina. The EXACT Phase 2 Trial. Improved Symptoms, Exercise Tolerance and Ischemia at 12months with VEGF Gene Therapy. A simultaneous publication with #SCAI2024 @SCAI @faisalbakaeen #cardiotwitter #AHAJournals https://t.co/EEvDQp1jwa

[Kenta Nakamura @KentaMD]

@JSawallaGusehMD @chrisryanburke @KateKearney4 @DrBillLombardi @PatrickGoleski @DrKelleyBranch @UWMedicine Thanks, Sawalla! To think I got my start with novel cardiac therapies with KP now 10 years ago!

[SCAI @SCAI]

@RFazel @MyJSCAI @HenrytTimothy @YChatzizisis @JDawnAbbott1 @Radial_ICG @mbmcentegart @KentaMD @adnanalkhouli @mitchbk1 Next, @KentaMD shares their #LateBreaking research: VEGF Gene Therapy Improves Exercise Time, #Ischemia, and Symptoms in Patients with Refractory #Angina: Results of the Phase II EXACT Trial. Learn more ➡️ https://t.co/KrQzRqZCiW #SCAI2024 @MyJSCAI

[Kenta Nakamura @KentaMD]

@rwyeh @EricSecemskyMD @SmithBIDMC Congrats, Eric!

[Ping Ong MD PhD @laypingong1]

Pleased to welcome Dr.Kenta Nakamura @KentaMD to @Cambridge_Uni to share his translational research in stem cell based cardiac remuscularization; part of Murry Lab’s mission to regenerate 💔 @UWISCRM @UWCardiology @SilviaMarchia @ketakimhatre @ElahehKarbassi @LabSinha @DrCathyWilson #teamscience 🚀

[Silvia Marchiano @SilviaMarchia]

How it started vs how it’s going
One of the major roadblocks for #heartreneration is the onset of arrhythmias after hPSC-CMs #celltherapy.
We were finally able to overcome this adverse reaction with the #MEDUSA project, published this week on @CellStemCell; so proud of our team!

[Ada C. Stefanescu Schmidt, MD MSc FACC @DrAdaStefanescu]

🤩 with Mr Chair @DougDrachmanMD and amazing mentor @ddefariayeh and friends @MGHHeartHealth grads! What joy!

[Amanda Elliott @AmyIsMyNickname]

🎉 Our #GWAS of gestational diabetes in #FinnGen is now available on medrxiv! We disentangle the genetic relationship of GDM with Type 2 diabetes using new methods we think could be much more broadly useful.
A brief thread 🧵 1/7
https://t.co/VEJISlCyXX

[Kenta Nakamura @KentaMD]

@pmjboyle @kellystevenslab Congrats!!

[Kenta Nakamura @KentaMD]

@FMoussaviHarami @nih_nhlbi @MichaelRegnier9 @JD98119 @JC_Tardiff @UWCardiology @UW_CTMR @UWISCRM @UWBioE Belated congratulations!

[Kenta Nakamura @KentaMD]

@Drbenderignacio @jordanprutkin Perpetual 2 year timeline OK? If not, I know some people who’ll hook you up from the mainline, backwards @KateKearney4 @DrBillLombardi

[Kenta Nakamura @KentaMD]

Congrats to @chrisryanburke and surgical team for first cardiac gene therapy at @UWMedicine. Many thanks to @UWMedHeart Clinical Trials Unit @KateKearney4 @DrBillLombardi and sponsor XyloCor for this milestone towards novel regenerative therapies for our patients.

[UWashington Heart Institute @UWMedHeart]

@KentaMD introduces a new clinical trial with human vascular endothelial growth factor (VEGF) to induce therapeutic angiogenesis.

@UWMedicine is one of two trial sites on the west coast.

More info available @ https://t.co/HUitdaFMKR

#MedTwitter #clinicaltrials @uwmnewsroom

[Kenta Nakamura @KentaMD]

Proud of our team tackling the challenges ahead for genuine cardiac remuscularization. Thank you Lauren Neidig @SilviaMarchia @berteroale @MRobinsonEP, Chuck Murry and Robb MacLellan and @UWMedicine for one step of many towards offering this strategy to our patients.

[StemCellReports @stemcellreports]

The new issue is now online. Read the latest research including the cover report on pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes https://t.co/YQchufX1zw. @UWISCRM @UWMedicine @uwmnewsroom @martinperaJAX @ISSCR